Men With Angina Do Worse Than Women
... that men diagnosed with the chest pain called angina did much worse than women, and neither ... The study of 1,785 people newly diagnosed with angina at 40 primary-care practices in Scotland ... it should be chosen more carefully than they are. angina is an early stage of heart disease. At that ...Depression, Anxiety Bad for the Heart
... Two new studies show effects on angina and mortality MONDAY, June 29 ... with stress tests, patients who have a lot of angina should be screened for anxiety and depression, ... imaging. They found that 36 percent reported no angina in the previous month, with 35 percent reporting ...AstraZeneca Announces TOPROL-XL(R) (Metoprolol Succinate) is Now Available
... antihypertensives; the long-term treatment of angina pectoris; and the treatment of stable, ... certain beta-blocking agents, exacerbations of angina pectoris and, in some cases, myocardial ... clinical trials of patients with hypertension and angina pectoris the most common adverse events reported ...Stem Cell Injections Seem to Reduce Angina Pain
... for those patients with currently untreatable angina to be more active with less pain." The phase 2 study included 167 adults with severe angina who were on maximal medical therapy and were not ... It also took longer until they experienced angina pain while walking on the treadmill, and the pain ...Angioplasty Not Always Worth the Price
... it appeared the use of stents and additional angina associated with that was expensive." But this ... years. Researchers compared the cost of treating angina in Canada, the U.S. non-VA health system and the ... The overall cost per patient related to angina frequency (as assessed by a patient ...CVT Announces That FDA Continues to Review Ranexa(R) Applications
... indication for first line treatment of chronic angina and a significant reduction in cautionary ... currently indicated for the treatment of chronic angina in patients who have not achieved an adequate ... tablets), indicated for the treatment of chronic angina in patients who have not achieved an ...Cardiogenesis Announces Preliminary Results Combining TMR + Platelet Rich Plasma (PRP)
... peripheral blood. At six months, a blinded angina assessment demonstrated: -- Both groups achieved significant angina relief. -- The TMR + PRP group had a lower average angina score (0.4 vs 1.7, p=0.07) than the TMR alone ...Angina drug potentially useful against heart rhythm disorders
... A recently approved angina drug may also represent a powerful new treatment ... in January 2006, might influence QTc during its angina clinical trials, where it was found to have ... Past studies have shown that people with angina are also at risk for rhythm disorders, said ...Surgery More Likely Than Angioplasty to Relieve Pain for Patients With Coronary Artery Disease
... are more likely to get relief from painful angina and less likely to have repeat procedures if they ... who undergo bypass surgery are free of angina pain 1 year after the procedure, compared with ... which equalizes after 3 years, was attributed to angina relief. The new report, Comparative ...Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
... antihypertensives; the long- term treatment of angina pectoris; and the treatment of ... clinical trials of patients with hypertension and angina pectoris, the most common adverse events reported ... beta-blocking agents, exacerbations of angina pectoris and, is some cases, myocardial ...PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S.
... alleviate symptoms of severe angina. CO2 TMR offers a treatment option for angina patients who suffer from severe coronary artery disease. The C02 Heart Laser is the world's first TMR angina relief device cleared for commercial distribution by both the U.S. Food ...External CounterPulsation (ECP) Centers
Description:... Looking for a way to help your patients with chronic angina or end stage cardiovascular disease? Based on the outcomes of several thousand cardiac patients nationwide, External Counterpulsation (ECP) has ...Transmedex Monitoring Services
Description:... devices that provide enhanced diagnostic analysis and fast data delivery using standard telephone lines. TransMedEx's product line includes the first angina Monitor; a 12-lead, Web-enabled Holter monitoring system; a long-term Ambulatory Blood Pressure Monitor; transtelephonic cardiac event monitoring ...NCP-2 External Counterpulsation Device
Features:... adjust platform levels for patient comfort and compliance. The raised edges of the treatment platform provide increased stability for your CHF and angina patients Control station is designed with mobility to accommodate most ECP treatment rooms First ever ECP Treatment Report is displayed on a ...Unexplained chest pain can be due to stress
... of time, compared with patients suffering from angina and patients who had suffered a heart attack. A ... then levelled out. The number of patients with angina increased up until 1994 and has since fallen, ... ill, compared with patients that became ill with angina or suffered heart attacks. Deaths among men a ...New beta-blocker to offer hope to heart and lung sufferers
... the Seeding Drug Discovery initiative, to conduct a three-year study to develop a modified type of beta-blocker that will treat heart disease and angina without exacerbating any underlying respiratory problems.. If successful, the new drug could become the general medicine of choice for all heart ...Findings released from 1 of the largest percutaneous coronary intervention trials ever
... in less bleeding and similar rates of composite ischemia compared to heparin plus GPI in patients undergoing angioplasty for stable angina, unstable angina and non-ST-elevation myocardial infarction (NSTEMI). Dr. Stone emphasized the importance of reducing the risk of bleeding. In multiple ...Proteins that stop a major signaling pathway can also generate new proteins
... everything from heart rate to mood. Research on GPCRs has led to numerous successful drugs, including beta blockers which help relieve hypertension, angina and coronary disease, as well as new antihistamines and ulcer drugs. They also formed the basis of Nobel Prize winning work on smell receptors. ...Study locates cholesterol genes; finds surprises about good, bad cholesterol
... amount of cholesterol and other lipids in the bloodstream contribute to the risk of coronary artery disease, which can cause heart attack, stroke, angina and other heart conditions. Both genetic and environmental factors influence a person's cholesterol and blood lipid levels. "Finding new gene ...20th ECNP Congress 2007, Oct. 13-17, Vienna, Austria
... has demonstrated (Wittchen et al 2005). Depression, for instance, produces the greatest decrement in health compared with the common chronic diseases angina pectoris, arthritis, asthma, and diabetes (Moussavi et al., 2007) followed by addictive disorders (nicotine, alcohol, drugs). Unmet needs for mental ...Evidence for omega 3 fats less conclusive than we thought, say experts
... should be reviewed regularly, say the authors. However, it is probably not appropriate to recommend a high intake of omega 3 fats for people who have angina but have not had a heart attack. To understand the effects of omega 3 fats on health, we need more high quality randomised controlled trials of ...Women feel more pain than men, research shows
... which are more predominant in women than men that influences women's experiences of pain. "Chest pain is associated with coronary heart disease, angina and heart attacks, so it is understandable that chest pain is a cause of great anxiety for patients and that anxiety has an important role in the ...Survival of heart patients on beta-blockers varies greatly with genetic variation
... Survival of heart attack and unstable angina patients placed on beta-blocker therapy corresponds to specific variations in their genes, according to a study by researchers at Washington ...CV Therapeutics Announces Presentations at American Heart Association Scientific Sessions 2008
... Morbidity and Mortality among Patients with angina and Multivessel Coronary Artery Disease in the ... tablets), indicated for the treatment of chronic angina in patients who have not achieved an ... the symptomatic treatment of patients with stable angina pectoris who are inadequately controlled or ...CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group
... the symptomatic treatment of patients with stable angina pectoris who are inadequately controlled or ... is indicated for the treatment of chronic angina in patients who have not achieved an adequate ... labeling for Ranexa to include a first line angina indication, a significant reduction in cautionary ...CV Therapeutics Announces Ranexa(R) Named Finalist for Prix Galien USA 2008 Award
... (Nasdaq: CVTX ) today announced that its chronic angina therapy Ranexa(R) (ranolazine extended-releases ... is indicated for the treatment of chronic angina in patients who have not achieved an adequate ... the symptomatic treatment of patients with stable angina pectoris who are inadequately controlled ...Cardium Launches New AWARE Clinical Study Website
... flow within the heart muscle) and associated angina due to coronary heart disease. Generx is designed ... ) The AWARE (Angiogenesis in Women with angina pectoris who are not candidates for ... approximately 300 women with recurrent stable angina pectoris who are not candidates ...CV Therapeutics to Announce 2008 Third Quarter Financial Results on Thursday, November 6, 2008
... extended-release tablets), indicated for the treatment of chronic angina in patients who have not achieved an adequate response with other ... as add-on therapy for the symptomatic treatment of patients with stable angina pectoris who are inadequately controlled or intolerant to first-line ...CV Therapeutics Receives European Approval for the Brand Name Ranexa(R)
... as an add-on therapy for the symptomatic treatment of patients with stable angina pectoris who are inadequately controlled or intolerant to first-line ... extended-release tablets), indicated for the treatment of chronic angina in patients who have not achieved an adequate response with other ...